REGENERON PHARMACEUTICALS, INC.REGN

Market cap
$993億
P/E ratio
25.1
2010年
12月31日
2011年
12月31日
2012年
12月31日
2013年
12月31日
2014年
12月31日
2015年
12月31日
2016年
12月31日
2017年
12月31日
2018年
12月31日
2019年
12月31日
2020年
12月31日
2021年
12月31日
2022年
12月31日
2023年
12月31日
Product4,1064,8345,56812,1176,8947,078
Sanofi collaboration revenue2,856
Collaboration revenue1,9022,0585,503
Collaboration revenue1,9022,0585,503
Other revenue1,1111,4271,186281365536
Other revenue1,1111,4271,186281365536
Revenue from contract with customer4594461,3782,1052,8204,1044,8605,8726,7117,8638,49716,07212,17313,117
Research and development4895306268601,2711,6212,0522,0752,1863,0372,7352,9083,5934,439
Acquired in-process research and development255186
Selling, general, and administrative651172113295058391,1781,3201,5561,8351,3461,8252,1162,631
Product1803624921,773800932
Cost of collaboration and contract manufacturing254420628664760884
Cost of collaboration and contract manufacturing254420628664760884
Other operating (income) expense, net28046902
Total expenses5576519211,3451,9812,8523,5303,7934,1765,6544,9217,1257,4349,070
Income from operations-97-2054587608381,2521,3312,0802,5342,2103,5778,9474,7394,047
Other income (expense), net662447250291436179225
Interest expense92145463714283057575973
Total other income (expense)-7-18-43-47-63-27-1-119219234379120152
Income before income taxes-104-2234147137761,2251,3302,0792,5542,4293,8109,3264,8594,199
Income tax expense-1-3362894285894348801093132971,251520246
Net income-104-2227504243486368961,1992,4442,1163,5138,0754,3383,954
Earnings Per Share, Basic7.924.333.466.178.5511.2722.6519.3832.6576.440.5137.05
Earnings Per Share, Diluted6.753.813.075.527.710.3421.2918.4630.5271.9738.2234.77
Net income-104-2227504243486368961,1992,4442,1163,5138,0754,3383,954
Unrealized gain (loss) on debt securities1-053-44-2113-7369-56-214158
Unrealized gain on cash flow hedges-2-111
Loss on foreign currency translation-0
Unrealized gain on cash flow hedges-2-111
Comprehensive income7514244025928741,2122,4382,1493,5218,0204,1264,112